Selected Financial Data
since 2019
Income Statement
Shockwave Medical Inc., selected items from income statement, long-term trends
US$ in thousands
| 12 months ended: | Revenue | Income (loss) from operations | Net income (loss) |
|---|---|---|---|
| Dec 31, 2023 | 730,230) | 159,093) | 147,278) |
| Dec 31, 2022 | 489,733) | 124,134) | 215,996) |
| Dec 31, 2021 | 237,146) | (871) | (9,136) |
| Dec 31, 2020 | 67,789) | (65,663) | (65,699) |
| Dec 31, 2019 | 42,927) | (51,839) | (51,109) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
Balance Sheet: Assets
Shockwave Medical Inc., selected items from assets, long-term trends
US$ in thousands
| Current assets | Total assets | |
|---|---|---|
| Dec 31, 2023 | 1,225,260) | 1,566,563) |
| Dec 31, 2022 | 459,263) | 646,089) |
| Dec 31, 2021 | 285,902) | 345,682) |
| Dec 31, 2020 | 246,300) | 272,042) |
| Dec 31, 2019 | 216,697) | 231,938) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
Balance Sheet: Liabilities and Stockholders’ Equity
Shockwave Medical Inc., selected items from liabilities and stockholders’ equity, long-term trends
US$ in thousands
| Current liabilities | Total liabilities | Total debt | Stockholders’ equity | |
|---|---|---|---|---|
| Dec 31, 2023 | 104,205) | 897,886) | 731,863) | 668,677) |
| Dec 31, 2022 | 63,374) | 134,773) | 24,198) | 511,316) |
| Dec 31, 2021 | 51,628) | 103,852) | 17,130) | 241,830) |
| Dec 31, 2020 | 25,581) | 46,388) | 16,619) | 225,654) |
| Dec 31, 2019 | 24,008) | 39,285) | 13,819) | 192,653) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
Cash Flow Statement
Shockwave Medical Inc., selected items from cash flow statement, long-term trends
US$ in thousands
| 12 months ended: | Net cash provided by (used in) operating activities | Net cash (used in) provided by investing activities | Net cash provided by (used in) financing activities |
|---|---|---|---|
| Dec 31, 2023 | 196,053) | (625,727) | 600,401) |
| Dec 31, 2022 | 117,732) | (62,150) | 12,999) |
| Dec 31, 2021 | 15,036) | 26,416) | (2,451) |
| Dec 31, 2020 | (71,184) | (107,473) | 90,035) |
| Dec 31, 2019 | (48,107) | (59,543) | 208,052) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
Per Share Data
Shockwave Medical Inc., selected data per share, long-term trends
US$
| 12 months ended: | Basic earnings per share 1 | Diluted earnings per share 2 | Dividend per share 3 |
|---|---|---|---|
| Dec 31, 2023 | 4.01 | 3.85 | 0.00 |
| Dec 31, 2022 | 6.02 | 5.70 | 0.00 |
| Dec 31, 2021 | -0.26 | -0.26 | 0.00 |
| Dec 31, 2020 | -1.99 | -1.99 | 0.00 |
| Dec 31, 2019 | -2.14 | -2.14 | 0.00 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1, 2, 3 Data adjusted for splits and stock dividends.